Jilin Province Huinan Changlong Bio-pharmacy Company Limited (HKG:8049)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.120
+0.010 (0.47%)
At close: Mar 10, 2026

Jilin Province Huinan Changlong Bio-pharmacy Company Company Description

Jilin Province Huinan Changlong Bio-pharmacy Company Limited manufactures and distributes Chinese medicines and pharmaceutical products in the People’s Republic of China.

The company provides Edaravone injection, compound brain comfort capsules, haikun kidney capsules, cefpirome sulfate for injections, Cefpiramide for injections, anti-bone hyperplasia tablets, Lysine zinc gluconate tablets, and Qianlie Guihuang Tablets.

It markets its products under the Changlong and Qing Tong brands. The company also engages in the manufacture and distribution of beverages and prepackaged food.

The company was formerly known as Jilin Province Huinan Biochemical Pharmaceutical Company Limited. Jilin Province Huinan Changlong Bio-pharmacy Company Limited was founded in 1989 and is based in Kowloon, Hong Kong.

Jilin Province Huinan Changlong Bio-pharmacy Company Limited
Country China
Founded 1989
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 798
CEO Hong Zhang

Contact Details

Address:
Grand Plaza, Office Tower Two
Kowloon
Hong Kong
Phone 86 435 821 8333
Website jlchanglong.com

Stock Details

Ticker Symbol 8049
Exchange Hong Kong Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE100000130
SIC Code 2834

Key Executives

Name Position
Hong Zhang Executive Chairman, Chief Executive Officer and Compliance Officer
Bao Gang Zhao Chief Financial Officer and Executive Director
Xiang Fu Xu Deputy Technical GM and Executive Director
Guo Wen Wu Deputy Sales Director and Executive Director
Xiao Guang Zhang GM and Executive Director
Yi Zhang Executive GM and Executive Director
Sai Cheong Mok ACCA, C.P.A., FCCA Company Secretary